Explore

Trendline Trendline
Stealth BioTherapeutics Appoints David A. Brown as Chief Scientific Officer to Enhance Mitochondrial Medicine Efforts

Stealth BioTherapeutics Appoints David A. Brown as Chief Scientific Officer to Enhance Mitochondrial Medicine Efforts

Stealth BioTherapeutics Appoints David A. Brown as Chief Scientific Officer to Enhance Mitochondrial Medicine Efforts
Trendline Trendline
Innocan Pharma Secures Additional Funding Through Debenture Offering

Innocan Pharma Secures Additional Funding Through Debenture Offering

Innocan Pharma Secures Additional Funding Through Debenture Offering
Trendline Trendline
Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research

Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research

Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research
Trendline Trendline
Activist Investor Criticizes Novavax Over Vaccine Sales and Management Strategy

Activist Investor Criticizes Novavax Over Vaccine Sales and Management Strategy

Activist Investor Criticizes Novavax Over Vaccine Sales and Management Strategy
Trendline Trendline
enGene Announces Corporate Name Change to enGene Therapeutics Inc. Reflecting Commercial Transition

enGene Announces Corporate Name Change to enGene Therapeutics Inc. Reflecting Commercial Transition

enGene Announces Corporate Name Change to enGene Therapeutics Inc. Reflecting Commercial Transition
Trendline Trendline
Insmed Halts Development of Skin Treatment Amid Competitive Advances

Insmed Halts Development of Skin Treatment Amid Competitive Advances

Insmed Halts Development of Skin Treatment Amid Competitive Advances
Trendline Trendline
ImmunityBio Responds to FDA Concerns, Enhances Advertising Compliance Protocols

ImmunityBio Responds to FDA Concerns, Enhances Advertising Compliance Protocols

ImmunityBio Responds to FDA Concerns, Enhances Advertising Compliance Protocols
Trendline Trendline
Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities

Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities

Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities
Trendline Trendline
Tapestry, Inc. Appoints Pinterest CTO Matt Madrigal to Board of Directors, Enhancing Tech Expertise

Tapestry, Inc. Appoints Pinterest CTO Matt Madrigal to Board of Directors, Enhancing Tech Expertise

Tapestry, Inc. Appoints Pinterest CTO Matt Madrigal to Board of Directors, Enhancing Tech Expertise
Trendline Trendline
Tapestry, Inc. Appoints Pinterest CTO Matt Madrigal to Board, Enhancing Tech Expertise

Tapestry, Inc. Appoints Pinterest CTO Matt Madrigal to Board, Enhancing Tech Expertise

Tapestry, Inc. Appoints Pinterest CTO Matt Madrigal to Board, Enhancing Tech Expertise
Trendline Trendline
Stephanie Lundquist and Bryan Jordan Join Securian Financial Board of Directors

Stephanie Lundquist and Bryan Jordan Join Securian Financial Board of Directors

Stephanie Lundquist and Bryan Jordan Join Securian Financial Board of Directors
Trendline Trendline
Doubts Emerge Over OpenAI CEO Sam Altman's Leadership Amid AI Expansion

Doubts Emerge Over OpenAI CEO Sam Altman's Leadership Amid AI Expansion

Doubts Emerge Over OpenAI CEO Sam Altman's Leadership Amid AI Expansion